Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 4528906, 11 pages
http://dx.doi.org/10.1155/2016/4528906
Research Article

Targeting Pin1 Protects Mouse Cardiomyocytes from High-Dose Alcohol-Induced Apoptosis

1Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
2Department of Inpatient Abdominal Ultrasonography, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
3Department of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China

Received 16 June 2015; Revised 19 August 2015; Accepted 23 August 2015

Academic Editor: Rakesh K. Singh

Copyright © 2016 Yuehong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Urbano-Márquez and J. Fernández-Solà, “Alcohol consumption and heart failure,” Journal of Cardiac Failure, vol. 11, no. 5, pp. 329–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. R. Piano, “Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology,” Chest, vol. 121, no. 5, pp. 1638–1650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Fauchier, D. Babuty, P. Poret et al., “Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy,” European Heart Journal, vol. 21, no. 4, pp. 306–314, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Fernández-Solà, R. Estruch, J.-M. Nicolás et al., “Comparison of alcoholic cardiomyopathy in women versus men,” American Journal of Cardiology, vol. 80, no. 4, pp. 481–485, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. A. George and V. M. Figueredo, “Alcoholic cardiomyopathy: a review,” Journal of Cardiac Failure, vol. 17, no. 10, pp. 844–849, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Fernández-Solà, F. Fatjó, E. Sacanella et al., “Evidence of apoptosis in alcoholic cardiomyopathy,” Human Pathology, vol. 37, no. 8, pp. 1100–1110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. B. Chen, L. Wang, and P. H. Wang, “Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes,” Life Sciences, vol. 67, no. 14, pp. 1683–1693, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Guan, C. Y. Lui, E. Morkin, and J. J. Bahl, “Oxidative stress and apoptosis in cardiomyocyte induced by high-dose alcohol,” Journal of Cardiovascular Pharmacology, vol. 44, no. 6, pp. 696–702, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Capasso, P. Li, G. Guideri, A. Malhotra, R. Cortese, and P. Anversa, “Myocardial mechanical, biochemical, and structural alterations induced by chronic ethanol ingestion in rats,” Circulation Research, vol. 71, no. 2, pp. 346–356, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Jing, C.-M. Jin, S.-S. Li et al., “Chronic alcohol intake-induced oxidative stress and apoptosis: role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy,” Molecular and Cellular Biochemistry, vol. 359, no. 1-2, pp. 283–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Wang, J. Zhao, W. Yang et al., “High-dose alcohol induces reactive oxygen species-mediated apoptosis via PKC-beta/p66Shc in mouse primary cardiomyocytes,” Biochemical and Biophysical Research Communications, vol. 456, no. 2, pp. 656–661, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. F. Göthel and M. A. Marahiel, “Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts,” Cellular and Molecular Life Sciences, vol. 55, no. 3, pp. 423–436, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. K. P. Lu, G. Finn, T. H. Lee, and L. K. Nicholson, “Prolyl cis-trans isomerization as a molecular timer,” Nature Chemical Biology, vol. 3, no. 10, pp. 619–629, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Marsolier and J. B. Weitzman, “Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers,” Médecine/Sciences, vol. 30, no. 8-9, pp. 772–778, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ryo, M. Nakamura, G. Wulf, Y.-C. Liou, and K. P. Lu, “Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC,” Nature Cell Biology, vol. 3, no. 9, pp. 793–801, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. G. M. Wulf, A. Ryo, G. G. Wulf et al., “Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1,” The EMBO Journal, vol. 20, no. 13, pp. 3459–3472, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-W. Cheng, A. K. M. Chow, R. Pang, E. W. S. Fok, Y.-L. Kwong, and E. Tse, “PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin,” The American Journal of Pathology, vol. 182, no. 3, pp. 765–775, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhu, L. Qin, M. Li, D. Zhang, Y. Zhang, and N. Cheng, “Pin1 expression affects cell proliferation and apoptosis of SW620 cells in colorectal carcinoma,” The Chinese-German Journal of Clinical Oncology, vol. 10, no. 2, pp. 100–104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Ehler, T. Moore-Morris, and S. Lange, “Isolation and culture of neonatal mouse cardiomyocytes,” Journal of Visualized Experiments, no. 79, Article ID e50154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. B. Yaffe, M. Schutkowski, M. Shen et al., “Sequence-specific and phosphorylation dependent proline isomerization: a potential mitotic regulatory mechanism,” Science, vol. 278, no. 5345, pp. 1957–1960, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Boussetta, M.-A. Gougerot-Pocidalo, G. Hayem et al., “The prolyl isomerase Pin1 acts as a novel molecular switch for TNF-α-induced priming of the NADPH oxidase in human neutrophils,” Blood, vol. 116, no. 26, pp. 5795–5802, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Chandra, I. Niemer, J. Gilbreath et al., “Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes,” Blood, vol. 92, no. 11, pp. 4220–4229, 1998. View at Google Scholar · View at Scopus
  23. F. Paneni, S. Costantino, L. Castello et al., “Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes,” European Heart Journal, vol. 36, no. 13, pp. 817–828, 2015. View at Publisher · View at Google Scholar
  24. H. M. Razavi, J. A. Hamilton, and Q. Feng, “Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure,” Pharmacology and Therapeutics, vol. 106, no. 2, pp. 147–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shen, L. Wang, G. Yang et al., “Baicalin protects the cardiomyocytes from ER stress-induced apoptosis: inhibition of CHOP through induction of endothelial nitric oxide synthase,” PLoS ONE, vol. 9, no. 2, Article ID e88389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Burger, M. Lei, N. Geoghegan-Morphet, X. Lu, A. Xenocostas, and Q. Feng, “Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase,” Cardiovascular Research, vol. 72, no. 1, pp. 51–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Bergendi, L. Beneš, Z. Ďuracková, and M. Ferenčik, “Chemistry, physiology and pathology of free radicals,” Life Sciences, vol. 65, no. 18-19, pp. 1865–1874, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. M. L. Circu and T. Y. Aw, “Reactive oxygen species, cellular redox systems, and apoptosis,” Free Radical Biology and Medicine, vol. 48, no. 6, pp. 749–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Ying and L. J. Hofseth, “An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer,” Cancer Research, vol. 67, no. 4, pp. 1407–1410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Kashiwagi, Y. Izumi, T. Gohongi et al., “NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels,” The Journal of Clinical Investigation, vol. 115, no. 7, pp. 1816–1827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Sasaki, S. Bharwani, P. Jordan et al., “Increased disease activity in eNOS-deficient mice in experimental colitis,” Free Radical Biology and Medicine, vol. 35, no. 12, pp. 1679–1687, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Wartenberg, M. Schallenberg, J. Hescheler, and H. Sauer, “Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids,” International Journal of Cancer, vol. 104, no. 3, pp. 274–282, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Marcocci, J. J. Maguire, M. T. Droy-Lefaix, and L. Packer, “The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761,” Biochemical and Biophysical Research Communications, vol. 201, no. 2, pp. 748–755, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Ruan, C. M. Torres, J. Qian et al., “Pin1 Prolyl isomerase regulates endothelial nitric oxide synthase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 2, pp. 392–398, 2011. View at Publisher · View at Google Scholar · View at Scopus